Results 1 to 10 of about 3,567 (147)

CKD-MBD diagnosis: biochemical abnormalities [PDF]

open access: yesBrazilian Journal of Nephrology, 2021
Leandro Junior Lucca   +3 more
doaj   +6 more sources

The Role of DMP1 in CKD-MBD. [PDF]

open access: yesCurr Osteoporos Rep, 2021
Chronic kidney disease-mineral and bone disorder (CKD-MBD) has become a global health crisis with very limited therapeutic options. Dentin matrix protein 1 (DMP1) is a matrix extracellular protein secreted by osteocytes that has generated recent interest for its possible involvement in CKD-MBD pathogenesis.
Martin A, Kentrup D.
europepmc   +3 more sources

Chronic Kidney Disease—Mineral and Bone Disorder (CKD-MBD), from Bench to Bedside

open access: yesKidney and Dialysis, 2023
Chronic kidney disease—mineral and bone disorder (CKD-MBD) is a systemic disorder that increases the risk of morbidity and mortality in dialysis patients.
Norio Hanafusa   +2 more
exaly   +3 more sources

Fucoidan Ameliorates Renal Injury-Related Calcium-Phosphorus Metabolic Disorder and Bone Abnormality in the CKD–MBD Model Rats by Targeting FGF23-Klotho Signaling Axis [PDF]

open access: yesFrontiers in Pharmacology, 2021
Background: Recently, chronic kidney disease (CKD)-mineral and bone disorder (MBD) has become one of common complications occurring in CKD patients. Therefore, development of a new treatment for CKD–MBD is very important in the clinic. In China, Fucoidan
Bu-Hui Liu   +13 more
doaj   +2 more sources

The Role of Vitamin K in CKD-MBD. [PDF]

open access: yesCurr Osteoporos Rep, 2022
We describe the mechanism of action of vitamin K, and its implication in cardiovascular disease, bone fractures, and inflammation to underline its protective role, especially in chronic kidney disease (CKD).Vitamin K acts as a coenzyme of y-glutamyl carboxylase, transforming undercarboxylated in carboxylated vitamin K-dependent proteins.
Fusaro M   +15 more
europepmc   +4 more sources

A Japanese approach for CKD-MBD

open access: yesKidney International Supplements, 2013
Disturbances in mineral and bone metabolism have a critical role in the pathogenesis of cardiovascular complications in patients with chronic kidney disease (CKD). The term 'renal osteodystrophy' has recently been replaced by 'CKD-mineral and bone disorder (CKD-MBD)', which includes abnormalities in bone and mineral metabolism and vascular ...
Keitaro Yokoyama   +2 more
exaly   +3 more sources

The Dietary Fiber Inulin Slows Progression of Chronic Kidney Disease–Mineral Bone Disorder (CKD‐MBD) in a Rat Model of CKD [PDF]

open access: yesJBMR Plus, 2023
Chronic kidney disease (CKD)–mineral bone disorder (CKD‐MBD) leads to fractures and cardiovascular disease. Observational studies suggest beneficial effects of dietary fiber on both bone and cardiovascular outcomes, but the effect of fiber on CKD‐MBD is ...
Annabel Biruete   +12 more
doaj   +2 more sources

Calciphylaxis: Beyond CKD-MBD

open access: yesNefrología (English Edition), 2017
Introduction: Calcific uraemic arteriolopathy (CUA), also called calciphylaxis, is a rare but potentially fatal vascular disorder that almost exclusively affects patients with chronic renal failure. The objective of this study was to analyse various risk
María Fernández   +6 more
doaj   +3 more sources

Machine learning based biomarker discovery for chronic kidney disease–mineral and bone disorder (CKD-MBD) [PDF]

open access: yesBMC Medical Informatics and Decision Making
Introduction Chronic kidney disease-mineral and bone disorder (CKD-MBD) is characterized by bone abnormalities, vascular calcification, and some other complications. Although there are diagnostic criteria for CKD-MBD, in situations when conducting target
Yuting Li   +9 more
doaj   +2 more sources

Evaluation of a Pharmacist–Dietician-Led Patient-Centered Approach to Managing CKD-MBD: A Mixed-Method Study [PDF]

open access: yesPharmacy, 2020
Chronic kidney disease mineral and bone disorder (CKD-MBD) is a common complication in end-stage renal disease (ESRD). To improve prescribing consistency and patient outcomes, a patient-centered, pharmacist–dietician-led approach to managing CKD-MBD was ...
Tamara Baker   +3 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy